Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2013-09-08 Director's Dealing
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notices 6 pages 107.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notices' and contains detailed disclosures about changes in securities holdings by company directors, including sales and purchases of shares and options. It references specific directors, dates of transactions, and complies with ASX listing rule 3.19A.2 and section 205G of the Corporations Act. The content focuses exclusively on personal share transactions by directors, which matches the definition of Director's Dealing filings. There is no indication of financial results, management commentary, or other report types. The document length and detail confirm it is not a brief announcement or certification but a full notice of director share dealings.
2013-09-08 English
Appendix 3B 7 pages 538.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an announcement dated 6 September 2013 from Nanosonics Limited regarding the exercise of employee share options and the issue of shares under the Nanosonics Employee Share Option Plan. It includes detailed information about the number and class of securities issued, terms of the securities, and compliance with relevant sections of the Corporations Act 2001. The document also contains an Appendix 3B, which is a standard form used in Australian securities markets to announce new issues of securities and apply for quotation of additional securities on the ASX. The content is focused on the issuance of shares and options, with no financial statements or performance data included. The document is a regulatory announcement about capital changes rather than a financial report or earnings release. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length (11,959 characters) is sufficient to be a full announcement rather than a brief notice or report publication announcement.
2013-09-05 English
South Korean regulator approves trophon EPR 1 page
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 30 August 2013 from Nanosonics Limited, reporting that the South Korean regulator (KFDA) has approved their product trophon EPR. The content focuses on regulatory approval and market expansion, with no financial data, no mention of shareholder votes, no management changes, no earnings or financial results, and no detailed report or presentation. The document length is short (2358 characters) and it is an announcement of a regulatory approval event rather than a financial or governance report. This fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements that do not fit other specific categories.
2013-08-29 English
New executive appointments for M Kavanagh and R Weinberger 2 pages 84.3KB
Board/Management Information Classification · 100% confidence The document is an announcement from Nanosonics Limited regarding the appointment of new senior executives, specifically the CEO and President, and a new President for Technology Development/Commercialisation. It discusses changes in the company's board and management structure but does not contain financial data, report publication, or regulatory filings. The content fits the category of Board/Management Information, as it announces changes in senior management positions and board membership.
2013-08-27 English
Nanosonics & Toshiba partnership gains ground 2 pages 165.8KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 23 August 2013 from Nanosonics Limited, reporting on a partnership with Toshiba and the installation of medical equipment (trophon EPR units) at a hospital. It discusses product adoption, market opportunity, and regulatory validation kits. There are no financial statements, earnings data, or detailed financial analysis. The document is a press release style announcement about business development and partnership progress rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Earnings Release, or Regulatory Filings. It is a general company announcement about a partnership and product deployment, which aligns best with Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2013-08-22 English
Investor Presentation 25 pages 1.2MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation given by the CEO at the Canaccord Growth Conference in August 2013. It includes company highlights, product descriptions, market analysis, sales and distribution updates, financial performance data, and future growth plans. The content is structured as a presentation with slides, charts, and tables, focusing on business strategy, market positioning, and financial metrics. There is no indication that this is an official annual or interim report, audit report, or earnings release. It is not a transcript of a call, nor a regulatory filing or announcement. The presence of detailed financial and strategic information aimed at investors and analysts classifies this document as an Investor Presentation (IP).
2013-08-14 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.